Skye Bioscience, Inc.
Nasdaq SKYE · San Diego, CA
Works in Metabolic & endocrine · Ophthalmology
Skye Bioscience, Inc. is a clinical trial sponsor based in San Diego, CA, listed as Nasdaq SKYE. It has 1 active clinical trial with 136 planned participants, in Metabolic & endocrine and Ophthalmology. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq SKYE
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Skye Bioscience, Inc
Skye Bioscience, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 136 planned participants, in Metabolic & endocrine, Ophthalmology. Since 2021 it has completed 1 trial and stopped 0 early.
Skye Bioscience, Inc is based in San Diego, CA and is listed as Nasdaq SKYE. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Skye Bioscience, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-01-14.
Approve Suite is not affiliated with Skye Bioscience, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.